China Custom Assays Market Report & Forecast 2021-2027

This report contains market size and forecasts of Custom Assays in China, including the following market information:
China Custom Assays Market Revenue, 2016-2021, 2022-2027, ($ millions)
China top five Custom Assays companies in 2020 (%)
The global Custom Assays market size is expected to growth from US$ 36690 million in 2020 to US$ 51450 million by 2027; it is expected to grow at a CAGR of 4.9% during 2021-2027.
The China Custom Assays market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Custom Assays Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Custom Assays Market,

By Type

, 2016-2021, 2022-2027 ($ Millions)
China Custom Assays Market Segment Percentages,

By Type

, 2020 (%)
Activity Assays
Competitive Assays
ELISA Assays
Screening Assays
Others

China Custom Assays Market,

By Application

, 2016-2021, 2022-2027 ($ Millions)
China Custom Assays Market Segment Percentages,

By Application

, 2020 (%)
Academic & Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Contract Research Organizations
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Custom Assays revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Custom Assays revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Bio-Rad
Roche Life Science
Fluidigm
Promega
Merck
GE Healthcare Lifescience
Cisbio
Biosensorix
ProeoGenix
Ethos Biosciences
Abzena
Agena Bioscience
Agilent
TissueMetrics
Eurofins Scientific
BioGenes GmbH
Eve Technologies
Quansys Bioscience